ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 103 filers reported holding ENDOCYTE INC in Q4 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $455,000 | -25.4% | 74,810 | -36.3% | 0.02% | -59.1% |
Q2 2015 | $610,000 | -17.1% | 117,500 | 0.0% | 0.04% | -22.8% |
Q1 2015 | $736,000 | -0.4% | 117,500 | 0.0% | 0.06% | +14.0% |
Q4 2014 | $739,000 | +62.4% | 117,500 | +57.1% | 0.05% | +42.9% |
Q3 2014 | $455,000 | – | 74,810 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Corbenic Partners LLC | 30,639 | $95,000 | 0.10% |
Leisure Capital Management | 29,655 | $92,000 | 0.09% |
Cribstone Capital Management, LLC | 32,541 | $101,000 | 0.08% |
HIGHLAND CAPITAL MANAGEMENT LP | 442,656 | $1,372,000 | 0.06% |
PINNACLE ASSOCIATES LTD | 898,096 | $2,784,000 | 0.06% |
Bellevue Group AG | 100,000 | $310,000 | 0.06% |
Baker Brothers Advisors | 1,695,865 | $5,257,000 | 0.06% |
Curi RMB Capital, LLC | 217,885 | $675,000 | 0.04% |
Spark Investment Management LLC | 116,300 | $360,000 | 0.04% |
OXFORD ASSET MANAGEMENT LLP | 244,192 | $757,000 | 0.02% |